NCT06058663 2025-10-20Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic CholangiocarcinomaMayo ClinicPhase 1 Recruiting16 enrolled
NCT05451043 2025-06-26Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)AHS Cancer Control AlbertaPhase 2 Recruiting62 enrolled